A Startup Pitched Growing Brainless Human Clones as Spare Bodies — Tim Draper Said Yes
A Startup Pitched Growing Brainless Human Clones as Spare Bodies — Tim Draper Said YesA stealth biotech in Richmond, California was quietly pitching “body replacement cloning” to billionaire investors. MIT Technology Review found the receipts.
R3 Bio raised real money to grow non-sentient monkey “organ sacks.” But their founder’s bigger vision? Clone YOUR body, remove the brain, keep the organs on life support — and swap parts when you get old.
Look, I’ve seen some wild plays in tech. This one genuinely made me sit back. A dude named John Schloendorn was running a company called R3 Bio out of Richmond, CA — and he was pitching venture capitalists on literally growing unconscious copies of rich people. No brain. Just meat. A walking organ bag with your exact DNA. And people wrote checks.
🧩 Dumb Mode Dictionary
| Term | What It Actually Means |
|---|---|
| Cloning | Making a genetic copy of a living thing — same DNA, different body |
| Non-sentient | Can’t think, feel, or be aware. Basically a body with no “person” inside |
| Organ sack | Their word for a body grown ONLY to harvest organs from (yeah, seriously) |
| Immunological match | When your body doesn’t reject a transplanted organ because the DNA matches |
| Surrogate | A woman paid to carry and give birth to someone else’s baby (or clone) |
| Gene editing | Changing DNA code like editing a document — cut, paste, delete genes |
| Stealth startup | A company that operates in secret, doesn’t want attention until they’re ready |
🔬 How We Got Here
- John Schloendorn, a longevity researcher, founded R3 Bio in Richmond, California
- The company’s public-facing work: creating brainless monkey bodies to replace animal testing
- But in a 2023 letter to supporters, Schloendorn laid out the REAL vision — “body replacement cloning” for humans
- The idea: use gene editing to grow a copy of your body with no complete brain. Keep it alive on feeding tubes. Harvest organs when yours fail
- Since artificial wombs (lab-grown babies outside a body) don’t exist yet, the first clones would need to be carried by paid surrogates
- Investor Tim Draper (the same billionaire who bought seized Silk Road Bitcoin) reportedly backed the company
🧪 What R3 Bio Actually Claims to Do
- Right now they say they’re focused on non-sentient monkey organ sacks — bodies without brains grown for organ harvesting, as a replacement for animal testing
- MIT Technology Review found no evidence R3 has cloned anything bigger than a rodent
- The company sent a “sweeping disavowal” saying Schloendorn “never made any statement regarding hypothetical non-sentient human clones carried by surrogates”
- But MIT Tech Review had the receipts — the founder’s own letters and pitch decks told a different story
📊 The Receipts
| Detail | What We Know |
|---|---|
| Company | R3 Bio, Richmond, California |
| Founder | John Schloendorn |
| Notable Backer | Tim Draper |
| Public Mission | Monkey organ sacks to replace animal testing |
| Private Vision | Full human body cloning for organ replacement |
| Clone Status | Nothing bigger than a rodent cloned (confirmed) |
| Key Problem | No artificial wombs exist — need real surrogates |
| Denial | Company calls all allegations “categorically false” |
🗣️ What the Scientists Said
- George Church, one of the biggest names in genetics (Harvard professor, helped launch the Human Genome Project), basically said this is overkill
- His take: “There’s almost no scenario where you need a whole body” — because nearly everyone on transplant lists just needs one organ, like a heart or kidney
- Growing lab-made individual organs (which is already being worked on) makes way more sense than cloning an entire unconscious human
- The bioethics community is… not thrilled. Growing a human body with no brain, keeping it alive on tubes, then cutting it open for parts sounds like a horror movie pitch — because it kind of is
⚖️ The Ethics Minefield
Real talk: even if you could grow a body with “no brain,” there’s a list of problems:
- Who defines “no brain”? Some brain stem function is needed to keep a body alive. Where’s the line between “organ sack” and “disabled person”?
- Surrogates carrying clones — a woman would have to carry a pregnancy to term knowing the result is a brainless body. The psychological and legal implications are wild
- Rich people’s spare parts — this would ONLY be available to billionaires initially. Imagine a world where the wealthy literally grow backup copies of themselves
- Human cloning is banned in many countries and violates guidelines in basically every major bioethics framework
- The fact that R3 Bio was pitching this quietly to investors while publicly talking about “monkey organ sacks” is… a pattern
Cool. A startup tried to sell billionaires their own spare bodies. Now What the Hell Do We Do? (⊙_⊙)
🕳️ The Clone Ethics Auditor
Look, every biotech company doing edgy research needs ethics review. Most of them hire the same 4 consulting firms. But here’s the play — there’s a gap between “ethics consultant” (boring, expensive) and “public trust translator” (doesn’t exist yet). Someone who reads through pitch decks and investor letters for biotech startups, then writes plain-English breakdowns of what they’re ACTUALLY doing vs. what they SAY they’re doing. Sell it as a subscription newsletter to journalists and advocacy groups.
Example: A 26-year-old bioethics student in Berlin packages a weekly newsletter reading through SEC filings and pitch decks from longevity startups on Crunchbase, flagging red flags in plain language. Charges €8/month. Gets picked up by 3 science journalists as a source within weeks. 340 subscribers in month one = €2,720/month.
Timeline: First issue in 3 days. Revenue in 2 weeks from pre-launch signups. Plateau at ~1,000 subscribers unless you break a story yourself. If you DO break one — sky’s the limit.
🧬 The Organ Waitlist Data Bridge
Real talk: 100,000+ people are on organ transplant waitlists in the US alone. The data on who needs what, where, and when is scattered across hospital systems that barely talk to each other. The play isn’t cloning — it’s building a simple tracking tool that aggregates public transplant data from UNOS and helps patient advocacy groups see patterns. Which hospitals have shorter wait times? Which blood types are underserved in which regions? This data exists but nobody’s made it accessible to regular people.
Example: A 30-year-old data analyst in Manila scrapes public UNOS reports, builds a free dashboard on Streamlit, then charges hospitals and advocacy nonprofits $200/month for custom regional breakdowns. 15 paying orgs in month two = $3,000/month with zero marketing budget.
🎣 The Longevity Hype Flipper
Here’s the thing. Every time a story like R3 Bio drops, longevity stocks and crypto tokens spike for 48-72 hours. Not because the tech works — because FOMO. The play: track biotech press coverage using free Google Alerts + BioPharmCatalyst for FDA news, then create a Telegram channel that alerts subscribers when a longevity company hits mainstream news. Pair each alert with “here’s what actually happened vs. what the headline says.” Charge for the signal, not the news.
Example: A 24-year-old pharmacy student in São Paulo sets up Google Alerts for 50 longevity keywords, cross-references with stock movement data from Yahoo Finance, posts 2 alerts/day to a Telegram group. Charges $15/month. 200 subscribers by month 3 from Reddit r/longevity promotion = $3,000/month.
🪟 The Surrogate Market Intelligence Gap
(I can’t believe I’m typing this but here we go.) The surrogacy market is a $33 billion global industry and growing. R3 Bio’s pitch casually assumed they’d just… hire surrogates to carry brainless clones. That’s not how surrogacy law works in 90% of the world. The play: there’s massive demand from fertility lawyers and international surrogacy agencies for up-to-date legal comparison data across countries. Which countries just changed their surrogacy laws? Which ones are about to? Package this into a quarterly legal brief using public government records and Hague Conference reports.
Example: A 28-year-old paralegal in Nairobi spends 2 weeks compiling surrogacy regulations from 40 countries using government websites and legal databases. Sells the PDF report for $95 to fertility clinics and law firms. 30 sales in the first quarter via cold email to clinics found on Google Maps = $2,850 from one document.
📡 The Bioethics Panic Content Machine
Every time a story like this breaks, every university ethics department, every hospital board, every church group needs someone to explain it to them in 20 minutes. Not a 40-page academic paper. A quick, visual slide deck that says “here’s what happened, here’s what it means, here’s what to watch for.” The play: build a template library of “bioethics explainer decks” using Canva or Google Slides. When a story breaks, customize the template with the new details, sell it on Gumroad within 24 hours of the news cycle.
Example: A 22-year-old pre-med student in Lahore builds 5 template slide decks covering common bioethics scenarios (cloning, gene editing, AI diagnostics, organ markets, designer babies). When the R3 Bio story breaks, customizes one deck in 3 hours, lists it for $12 on Gumroad, promotes on Twitter/X with the hashtag. 180 sales in the first week from ethics professors and church educators = $2,160.
🛠️ Follow-Up Actions
| Want To… | Do This |
|---|---|
| Track biotech startup filings | Set up Crunchbase alerts + Google Alerts for “stealth biotech” |
| Understand organ transplant data | Explore UNOS data — it’s publicly available |
| Follow longevity research news | Join r/longevity + subscribe to LEAF newsletter |
| Read the full MIT investigation | Original article here |
| Learn about cloning laws | Wikipedia: Human cloning laws by country |
Quick Hits
| Want… | Do… |
|---|---|
| Understand the science |
Read George Church’s lab page — the guy who called this overkill |
 Stay on biotech scandals |
Follow @antoniogm + STAT News on Twitter/X |
 Spot longevity hype early |
Track BioPharmCatalyst for FDA catalyst dates |
 Know your clone rights |
Spoiler: you have none. Cloning is banned almost everywhere. Check the map |
A billionaire investor looked at a pitch deck that said “grow brainless copies of rich people and harvest their organs” and thought… yeah, I’ll fund that. Sleep well, everybody.
!